Quinolone safety and efficacy more important than potency

Saved in:
Bibliographic Details
Published in:Emerging infectious diseases 2004-01, Vol.10 (1), p.156-157
Main Author: Frothingham, Richard
Format: Article
Language:English
Subjects:
Adult
Bacterial Infections - drug therapy
Community-Acquired Infections - drug therapy
Dose-Response Relationship, Drug
drug therapy
Female
Fluoroquinolone
Humans
Letter
levofloxacin
moxifloxacin
Pneumonia - drug therapy
Quinolones
Quinolones - adverse effects
Quinolones - therapeutic use
United States
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c628t-21f631fefacb366deda867c515c2077733f8c52a8115827037610fb6a61ce78d3
cites cdi_FETCH-LOGICAL-c628t-21f631fefacb366deda867c515c2077733f8c52a8115827037610fb6a61ce78d3
container_end_page 157
container_issue 1
container_start_page 156
container_title Emerging infectious diseases
container_volume 10
creator Frothingham, Richard
description
doi_str_mv 10.3201/eid1001.030307
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_837e3bef915f41578aeb3b9c73abb32a</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A112409770</galeid><doaj_id>oai_doaj_org_article_837e3bef915f41578aeb3b9c73abb32a</doaj_id><sourcerecordid>A112409770</sourcerecordid><originalsourceid>FETCH-LOGICAL-c628t-21f631fefacb366deda867c515c2077733f8c52a8115827037610fb6a61ce78d3</originalsourceid><addsrcrecordid>eNqNkktrGzEUhYfS0qRpt12WWRW6GFcPj6TZFELowxAIfW7FHc3VWGFGMpIc6n9fpTZpDF4ULSSuvnMkDqeqXlOy4IzQ9-gGSghdEF6WfFKdU6JII0jbPX04L8lZ9SKl28IVSfe8OqMtpUws5XnVfd06H6bgsU5gMe9q8EON1joDZlfPIWLt5k2IGXyu8xp8vQkZvdm9rJ5ZmBK-OuwX1c9PH39cfWmubz6vri6vGyOYyg2jVnBq0YLpuRADDqCENC1tDSNSSs6tMi0DRWmrmCRcCkpsL0BQg1IN_KJa7X2HALd6E90McacDOP13EOKoIWZnJtSKS-Q92o62dklbqQB73ndGcuh7zqB4fdh7bbb9jINBnyNMR6bHN96t9RjuNOeMSUGKQbM3GKG857wNBTMjeix0CdG6Mr4s4S5JJ-U9vzjBlzXg7MxJwbsjQWEy_s4jbFPSq-_f_p-9-XXMvn3ErhGmvE5h2mYXfDr5YxNDShHtQzqU6PvK6UPl9L5yRfDmcab_8EPH-B8OIs6U</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Quinolone safety and efficacy more important than potency</title><source>PubMed (Medline)</source><creator>Frothingham, Richard</creator><creatorcontrib>Frothingham, Richard</creatorcontrib><identifier>ISSN: 1080-6040</identifier><identifier>EISSN: 1080-6059</identifier><identifier>DOI: 10.3201/eid1001.030307</identifier><identifier>PMID: 15112647</identifier><language>eng</language><publisher>United States: U.S. National Center for Infectious Diseases</publisher><subject>Adult ; Bacterial Infections - drug therapy ; Community-Acquired Infections - drug therapy ; Dose-Response Relationship, Drug ; drug therapy ; Female ; Fluoroquinolone ; Humans ; Letter ; levofloxacin ; moxifloxacin ; Pneumonia - drug therapy ; Quinolones ; Quinolones - adverse effects ; Quinolones - therapeutic use ; United States</subject><ispartof>Emerging infectious diseases, 2004-01, Vol.10 (1), p.156-157</ispartof><rights>COPYRIGHT 2004 U.S. National Center for Infectious Diseases</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c628t-21f631fefacb366deda867c515c2077733f8c52a8115827037610fb6a61ce78d3</citedby><cites>FETCH-LOGICAL-c628t-21f631fefacb366deda867c515c2077733f8c52a8115827037610fb6a61ce78d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322760/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322760/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15112647$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Frothingham, Richard</creatorcontrib><title>Quinolone safety and efficacy more important than potency</title><title>Emerging infectious diseases</title><addtitle>Emerg Infect Dis</addtitle><subject>Adult</subject><subject>Bacterial Infections - drug therapy</subject><subject>Community-Acquired Infections - drug therapy</subject><subject>Dose-Response Relationship, Drug</subject><subject>drug therapy</subject><subject>Female</subject><subject>Fluoroquinolone</subject><subject>Humans</subject><subject>Letter</subject><subject>levofloxacin</subject><subject>moxifloxacin</subject><subject>Pneumonia - drug therapy</subject><subject>Quinolones</subject><subject>Quinolones - adverse effects</subject><subject>Quinolones - therapeutic use</subject><subject>United States</subject><issn>1080-6040</issn><issn>1080-6059</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNqNkktrGzEUhYfS0qRpt12WWRW6GFcPj6TZFELowxAIfW7FHc3VWGFGMpIc6n9fpTZpDF4ULSSuvnMkDqeqXlOy4IzQ9-gGSghdEF6WfFKdU6JII0jbPX04L8lZ9SKl28IVSfe8OqMtpUws5XnVfd06H6bgsU5gMe9q8EON1joDZlfPIWLt5k2IGXyu8xp8vQkZvdm9rJ5ZmBK-OuwX1c9PH39cfWmubz6vri6vGyOYyg2jVnBq0YLpuRADDqCENC1tDSNSSs6tMi0DRWmrmCRcCkpsL0BQg1IN_KJa7X2HALd6E90McacDOP13EOKoIWZnJtSKS-Q92o62dklbqQB73ndGcuh7zqB4fdh7bbb9jINBnyNMR6bHN96t9RjuNOeMSUGKQbM3GKG857wNBTMjeix0CdG6Mr4s4S5JJ-U9vzjBlzXg7MxJwbsjQWEy_s4jbFPSq-_f_p-9-XXMvn3ErhGmvE5h2mYXfDr5YxNDShHtQzqU6PvK6UPl9L5yRfDmcab_8EPH-B8OIs6U</recordid><startdate>200401</startdate><enddate>200401</enddate><creator>Frothingham, Richard</creator><general>U.S. National Center for Infectious Diseases</general><general>Centers for Disease Control and Prevention</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>200401</creationdate><title>Quinolone safety and efficacy more important than potency</title><author>Frothingham, Richard</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c628t-21f631fefacb366deda867c515c2077733f8c52a8115827037610fb6a61ce78d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adult</topic><topic>Bacterial Infections - drug therapy</topic><topic>Community-Acquired Infections - drug therapy</topic><topic>Dose-Response Relationship, Drug</topic><topic>drug therapy</topic><topic>Female</topic><topic>Fluoroquinolone</topic><topic>Humans</topic><topic>Letter</topic><topic>levofloxacin</topic><topic>moxifloxacin</topic><topic>Pneumonia - drug therapy</topic><topic>Quinolones</topic><topic>Quinolones - adverse effects</topic><topic>Quinolones - therapeutic use</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Frothingham, Richard</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Emerging infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Frothingham, Richard</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Quinolone safety and efficacy more important than potency</atitle><jtitle>Emerging infectious diseases</jtitle><addtitle>Emerg Infect Dis</addtitle><date>2004-01</date><risdate>2004</risdate><volume>10</volume><issue>1</issue><spage>156</spage><epage>157</epage><pages>156-157</pages><issn>1080-6040</issn><eissn>1080-6059</eissn><cop>United States</cop><pub>U.S. National Center for Infectious Diseases</pub><pmid>15112647</pmid><doi>10.3201/eid1001.030307</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1080-6040
ispartof Emerging infectious diseases, 2004-01, Vol.10 (1), p.156-157
issn 1080-6040
1080-6059
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_837e3bef915f41578aeb3b9c73abb32a
source PubMed (Medline)
subjects Adult
Bacterial Infections - drug therapy
Community-Acquired Infections - drug therapy
Dose-Response Relationship, Drug
drug therapy
Female
Fluoroquinolone
Humans
Letter
levofloxacin
moxifloxacin
Pneumonia - drug therapy
Quinolones
Quinolones - adverse effects
Quinolones - therapeutic use
United States
title Quinolone safety and efficacy more important than potency
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T03%3A28%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Quinolone%20safety%20and%20efficacy%20more%20important%20than%20potency&rft.jtitle=Emerging%20infectious%20diseases&rft.au=Frothingham,%20Richard&rft.date=2004-01&rft.volume=10&rft.issue=1&rft.spage=156&rft.epage=157&rft.pages=156-157&rft.issn=1080-6040&rft.eissn=1080-6059&rft_id=info:doi/10.3201/eid1001.030307&rft_dat=%3Cgale_doaj_%3EA112409770%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c628t-21f631fefacb366deda867c515c2077733f8c52a8115827037610fb6a61ce78d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/15112647&rft_galeid=A112409770&rfr_iscdi=true